Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Peter Kupchak"'
Autor:
Thomas R Cawthorn, Juan C Moreno, Moyez Dharsee, Danh Tran-Thanh, Suzanne Ackloo, Pei Hong Zhu, Girish Sardana, Jian Chen, Peter Kupchak, Lindsay M Jacks, Naomi A Miller, Bruce J Youngson, Vladimir Iakovlev, Cynthia J Guidos, Katherine A Vallis, Kenneth R Evans, David McCready, Wey L Leong, Susan J Done
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30992 (2012)
Breast cancer is the most common malignancy among women worldwide in terms of incidence and mortality. About 10% of North American women will be diagnosed with breast cancer during their lifetime and 20% of those will die of the disease. Breast cance
Externí odkaz:
https://doaj.org/article/5a7c1d53549b400eae687487a3a338ef
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 33:2594-2600
Objective: To assess efficacy of immunoassays to diagnose spontaneous rupture of membranes (SROM).Study design: We performed a prospective, observational analysis comparing two immunoassays designe...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14cecc90c0e2ba4140f2b668fa731a55
https://doi.org/10.1080/14767058.2018.1555809
https://doi.org/10.1080/14767058.2018.1555809
Autor:
Athos Bousvaros, Alanna Grob, Eugene Greenberg, David A Florez, Ashutosh Kumar, Felix Tiongco, James Leavitt, Jeffrey A Berinstein, Razvan Arsenescu, Keith Friedenberg, Calen A. Steiner, Robert Hardi, Shahriar Sedghi, K.T. Park, Alison Fint, Anthony Lembo, Peter Kupchak, Peter D.R. Higgins
Publikováno v:
Crohn's & Colitis 360. 1
Background Fecal calprotectin (fCAL) is a noninvasive biomarker used to differentiate between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Methods A multicenter prospective case–control study evaluating the BÜHLMANN fCAL en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1183bc27e5195d974b4396ff7bbc7004
https://doi.org/10.1093/crocol/otz037
https://doi.org/10.1093/crocol/otz037
Autor:
Qiang Ding, Heba W.Z. Khella, Maria D. Pasic, Fabio Rotondo, Henriett Butz, George M. Yousef, Peter Kupchak, Evi Lianidou, Georg A. Bjarnason, Kenneth R. Evans, Moyez Dharsee, Ashraf Latif
Publikováno v:
Molecular Therapy. 23:1748-1758
Sunitinib is a multitargeting tyrosine kinase inhibitor used for metastatic renal cancer. There are no biomarkers that can predict sunitinib response. Such markers are needed to avoid administration of costly medication with side effects to patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7282fb94438ef2f419e6fe9ae5fb4f0
https://doi.org/10.1038/mt.2015.129
https://doi.org/10.1038/mt.2015.129
Autor:
Hon Nian Chua, Peter Kupchak, Lorne Taylor, Craig E. Pennell, Stephen Tate, Stephen J. Lye, Brett Larsen, Mary W. F. Lee, Yujing J. Heng, Tony Pawson, Monika Tucholska, Soke May Pung
Publikováno v:
Journal of Proteome Research. 14:457-466
Threatened preterm labor (TPTL) accounts for ∼30% of pregnancy-related hospital admissions. Maternal peripheral leukocytes can be used to monitor a variety of physiological processes occurring in the body. Two high-throughput mass spectrometry meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24e254c7488b2598da05d5f64e262639
https://doi.org/10.1021/pr500852p
https://doi.org/10.1021/pr500852p
Autor:
Aileen K Ho, G. Bernhard Landwehrmeyer, J Giuliano, Ralf Reilmann, Jane S. Paulsen, Daniel P. van Kammen, John H. Warner, Beth Borowsky, Peter Kupchak, Kevin M. Biglan, Terrence Sills, Karen E. Anderson, Anthony L. Vaccarino, Andrew W. Michell, Christopher Kennard, Kenneth R. Evans, Mark Guttman
Publikováno v:
Europe PubMed Central
PLoS Currents
PLoS Currents
The Functional Rating Scale Taskforce for pre-Huntington Disease (FuRST-pHD) is a multinational, multidisciplinary initiative with the goal of developing a data-driven, comprehensive, psychometrically sound, rating scale for assessing symptoms and fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897dc06e3c9f93ca322aa27e7fd76c8e
https://ora.ox.ac.uk/objects/uuid:b09b0d51-f253-4ba8-b0d8-ed2d5a35a32c
https://ora.ox.ac.uk/objects/uuid:b09b0d51-f253-4ba8-b0d8-ed2d5a35a32c
Autor:
Eric Stanton, M. Hansen, Hairinda C. Wijeysundera, Jean L. Rouleau, Christian Hall, Peter Kupchak
Publikováno v:
European Journal of Heart Failure. 7:557-565
The natriuretic peptides have been validated as sensitive and specific markers of left ventricular dysfunction; brain natriuretic peptide (BNP), N-terminal atrial natriuretic peptide (NT-proANP) and N-terminal brain natriuretic peptide (NT-proBNP) el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f79fd99ff118f8619a9f0df46b2c6bde
https://doi.org/10.1016/j.ejheart.2004.06.004
https://doi.org/10.1016/j.ejheart.2004.06.004
Autor:
Kenneth R. Evans, Annika Fendler, Paulo Nuin, Aurfan Nasser, Moyez Dharsee, Sahar Al-Haddad, Carsten Stephan, Neil Fleshner, Carol Saleh, Klaus Jung, George M. Yousef, Peter Kupchak, Zsuzsanna Lichner, Dina Boles
Publikováno v:
Clinical chemistry. 59(11)
PURPOSE Prostate-specific antigen testing has led to overtreatment of prostate cancer (PCa). Only a small subset of PCa patients will have an aggressive disease that requires intensive therapy, and there is currently no biomarker to predict disease a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b082cf659cd81325d1662420a4c57ec
https://pubmed.ncbi.nlm.nih.gov/23958847
https://pubmed.ncbi.nlm.nih.gov/23958847
Autor:
David McCready, Naomi Miller, Thomas R. Cawthorn, Susan J. Done, Wey L. Leong, Danh Tran-Thanh, Bruce Youngson, Jian Chen, Katherine A. Vallis, Girish Sardana, Lindsay M. Jacks, Peter Kupchak, Suzanne Ackloo, Moyez Dharsee, Vladimir Iakovlev, Cynthia J. Guidos, Pei Hong Zhu, Kenneth R. Evans, Juan C. Moreno
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30992 (2012)
PLoS ONE
PLoS ONE
BACKGROUND: Breast cancer is the most common malignancy among women worldwide in terms of incidence and mortality. About 10% of North American women will be diagnosed with breast cancer during their lifetime and 20% of those will die of the disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb1674e242e4426584fee18036352c0
http://ora.ox.ac.uk/objects/uuid:30995d0c-ac83-480f-a5e3-3e3c8c675788
http://ora.ox.ac.uk/objects/uuid:30995d0c-ac83-480f-a5e3-3e3c8c675788